查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
橫向流動分析市場-全球行業規模、份額、趨勢、機會和預測，2018-2028 年，按產品類型、應用、技術、測試類型、最終用戶、地區、競爭
市場調查報告書
商品編碼
1255230

橫向流動分析市場-全球行業規模、份額、趨勢、機會和預測，2018-2028 年，按產品類型、應用、技術、測試類型、最終用戶、地區、競爭

Lateral Flow Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product, By Application, By Technique, By Test Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球側流分析市場預計在預測期內將出現顯著增長。

這是由於結核病、肝炎和流感等傳染病日益流行，以及對即時檢測的需求不斷增加。 同樣，在預測期內，越來越多地採用橫向流動分析試劑盒等新技術也有望帶來顯著增長。 此外，人口老齡化日益加劇，更容易患上各類慢性病，增加了對家庭檢測方法的需求。 預計這將在預測期內推動市場增長。 此外，提高公眾對新測試分析的認識也將推動市場增長到 2028 年。 在 2019-2020 流感季節，美國發生了 3600 萬例流感病例。 2019-2020 流感季節有 20,342 人死於流感。 在 2019-2020 年流感季節，流感導致的死亡大多數發生在 65 歲及以上的人群中。

傳染病傳播

由於慢性病的生理變化、代謝問題和免疫系統減弱，囊性纖維化、心血管疾病、肝炎和癌症等慢性病正在迅速增加，預計這將在預測期內推動市場增長。 同樣，改變健康的生活方式將推動各地區疾病的增加，預計這將在預測期內推動市場增長。 2020年9月，Qiagen N.V.收購了NeuMoDx Molecular, Inc.，擴大了Qiagen的診斷產品線，提升了其在自動化分子檢測領域的市場地位。 這擴大了 QIAGEN 提供的自動化測試解決方案的範圍，並為未來的增長提供了新的催化劑。 政府對使用新檢測方法的舉措和意識將在預測期內推動市場增長。 2021 年，美國 50 個州和哥倫比亞特區 (DC) 向 CDC 國家結核病監測系統 (NTSS) 初步報告了 7,860 例結核病病例。 由於不健康的食品消費導致艾滋病毒和瘧疾等傳染病日益流行，預計在預測期內將產生有利可圖的增長。 慢性病患病率的增加將增加對健康生活方式的需求，預計這將進一步推動市場增長。 2001 年全世界約 46% 的所有疾病和 5650 萬人死亡中的 60% 是由慢性病引起的。

對可以在家完成的測試方法的需求增加

用於慢性病檢測、妊娠檢測、生育力檢測、凝血檢測、尿液化學等的家庭檢測試劑盒的需求不斷增長，以及對即時檢測的需求不斷增長，將進一步推動對側流檢測的需求。,該設備使用量的快速增長可能會在預測期內進一步推動市場增長。 根據 Statista 的數據，2020 年美國有 792 萬女性使用了家庭妊娠試驗。 領先的公司專注於開發創新的基於橫向流動檢測的即時檢測設備，用於使用 HCG 水平和排卵進行妊娠檢測、傳染病廣告藥物護理和促進等應用。蛋白質標記物的測量有望加強對側流分析市場多年。 例如，2019年，美國Abbott公司開發了血液檢測“ARCHITECT stat Troponin I”，Siemens公司開發了用於臨床診斷的“CLINITEK Microalbumin 2 strips”。

近期發展

專業臨床診斷產品製造商 Novasito 宣布將推出 PathFlow COVID-19 抗原側流檢測 (LFT)，以加強其 COVID-19 產品組合併尋求新的市場機會，尤其是在床旁 ( POC）環境，我們將發布2個產品。 2020年9月，瑞士F. Hoffmann-La Roche, Ltd.推出SARS-CoV-2抗原快速檢測試劑盒和SARS-CoV-2抗體快速檢測試劑盒。

可自定義

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢概述

第 4 章 VOC（客戶之聲）

第 5 章側流分析的全球市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品（試劑盒/試劑、橫向流動閱讀器、其他）
    • 按應用（臨床測試、心臟標誌物測試、妊娠/生育力測試、獸醫診斷等）
    • 按方法（夾心試驗、競爭性試驗、多重檢測試驗）
    • 按測試類型（側流免疫分析/核酸側流分析）
    • 由最終用戶（醫院/診所、診斷機構等）
    • 按地區
    • 按公司分類（2022 年）
  • 市場地圖
    • 按產品分類
    • 通過申請
    • 按技術
    • 按測試類型
    • 最終用戶
    • 按地區

第 6 章北美側流分析的市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品（試劑盒/試劑、橫向流動閱讀器、其他）
    • 按應用（臨床測試、心臟標誌物測試、妊娠/生育力測試、獸醫診斷等）
    • 按方法（夾心試驗、競爭性試驗、多重檢測試驗）
    • 按測試類型（側流免疫分析/核酸）
    • 由最終用戶（醫院/診所、診斷機構等）
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章：歐洲側流分析市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品（試劑盒/試劑、橫向流動閱讀器、其他）
    • 按應用（臨床測試、心臟標誌物測試、妊娠/生育力測試、獸醫診斷等）
    • 按方法（夾心試驗、競爭性試驗、多重檢測試驗）
    • 按測試類型（側流免疫分析/核酸）
    • 由最終用戶（醫院/診所、診斷機構等）
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第 8 章亞太側流分析市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品（試劑盒/試劑、橫向流動閱讀器、其他）
    • 按應用（臨床測試、心臟標誌物測試、妊娠/生育力測試、獸醫診斷等）
    • 按方法（夾心試驗、競爭性試驗、多重檢測試驗）
    • 按測試類型（側流免疫分析/核酸）
    • 由最終用戶（醫院/診所、診斷機構等）
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳大利亞

第 9 章南美橫向流動分析市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品（試劑盒/試劑、橫向流動閱讀器、其他）
    • 按應用（臨床測試、心臟標誌物測試、妊娠/生育力測試、獸醫診斷等）
    • 按方法（夾心試驗、競爭性試驗、多重檢測試驗）
    • 按測試類型（側流免疫分析/核酸）
    • 由最終用戶（醫院/診所、診斷機構等）
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東和非洲側流分析市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品（試劑盒/試劑、橫向流動閱讀器、其他）
    • 按應用（臨床測試、心臟標誌物測試、妊娠/生育力測試、獸醫診斷等）
    • 按方法（夾心試驗、競爭性試驗、多重檢測試驗）
    • 按測試類型（側流免疫分析/核酸側流分析）
    • 由最終用戶（醫院/診所、診斷機構等）
    • 按國家
  • MEA：國家分析
    • 南非側流分析
    • 沙特阿拉伯側流分析
    • 阿聯酋側流分析

第 11 章市場動態

  • 司機
  • 任務

第12章市場趨勢與發展

  • 近期趨勢
  • 併購
  • 產品發布

第 13 章側流分析的全球市場：SWOT 分析

第 14 章波特的五力分析

  • 行業競爭
  • 新進入的可能性
  • 供應商的力量
  • 客戶力量
  • 替代品的威脅

第第十五章競爭格局

  • 業務概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT 分析
    • Thermo Fisher Scientific, Inc.
    • Abbott Laboratories, Inc.
    • F. Hoffmann-La Roche AG
    • Bio-Rad Laboratories, Inc.
    • Quidel Corporation
    • Hologic, Inc.
    • bioMerieux SA
    • PerkinElmer, Inc.
    • Danaher Corporation
    • QIAGEN N.V.

第 16 章戰略建議

簡介目錄
Product Code: 14323

The Global Lateral Flow Assay Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing prevalence of infectious diseases such as TB, Hepatitis, and Influenza STI, along with the growing demand for point-of-care testing. Similarly, the growing adoption of new technology like lateral flow assay kits is expected to create significant growth during the forecast period. Additionally, growing geriatric populations are susceptible to different types of chronic diseases, which enhances the demand for home-based testing methods. This, in turn, is expected to boost market growth during the forecast period. Besides, growing public awareness about the new testing assay is also propelling market growth through 2028. , during the 2019-2020 flu season, there were 36 million cases of influenza in the United States. The number of influenza deaths during the 2019-2020 flu season was 20,342. The vast majority of deaths attributed to influenza during the 2019-2020 flu season occurred among those aged 65 years and older.

Growing prevalence of infectious diseases

Chronic illnesses such as cystic fibrosis, cardiovascular diseases, hepatitis, and cancer are rapidly increasing due to physiological changes, metabolic problems, and low immune systems, and so the aging population is prone to these types of chronic diseases, which will enhance the growth of the market during the forecast period. Similarly, changing a healthy lifestyle will enhance disease growth across the region, and this, in turn, will boost the market growth during the forecast period. In September 2020, Qiagen N.V. bought NeuMoDx Molecular, Inc. to expand Qiagen's diagnostics instrument product line and boost its market position in automated molecular testing. This will broaden QIAGEN's offering of automated testing solutions and serve as another catalyst for future growth. Government initiative and awareness about using new assays will boost the market growth during the forecast period. During 2021, a total of 7,860 TB cases were provisionally reported to CDC's National Tuberculosis Surveillance System (NTSS) by the 50 U.S. states and the District of Columbia (DC). The increasing prevalence of infectious diseases like HIV and malaria due to consuming unhealthy food is expected to create lucrative growth during the forecast period. Due to the increasing prevalence of chronic diseases, demand leading a healthy lifestyle increased, which is further expected to drive the growth of the market over the years. Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions.

Increasing demand for home-based testing method

Rising demand for home-based testing kits for the detection of chronic diseases, pregnancy tests, fertility tests, coagulation tests, urine chemistry, etc., the growing demand for point-of-care testing may further enhance the demand for lateral flow assay, and usage of this device is rapidly increased which may further propel the growth of the market during the forecast period. According to this Statista, 7.92 million women in the U.S. used home pregnancy tests in 2020. Major companies are focusing on developing innovative lateral flow assay-based point-of-care devices for applications such as pregnancy tests by using HCG levels and ovulation, careening for infectious diseases ad drugs, and the measurement of protein markers in the boost is expected to enhance the demand for lateral flow assay market over the years. For instance, in 2019, Abbott Laboratories (US) developed its ARCHITECT stat Troponin I blood test, while Siemens AG developed the CLINITEK Microalbumin 2 strips for clinical diagnostics.

Market Segmentation

The global lateral flow assay market can be segmented by product, application, technique, test type, end-user, and by region. Based on the product, the market can be segmented into Kits & Reagents, Lateral Flow Readers, and Others. Based on application, the market can be segmented into Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, and Others. Based on technique, the market can be differentiated by Sandwich Assay, Competitive Assay, and Multiplex Detection Assay. Based on test type, the market can be divided into Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay. Based on end-user, the market can be differentiated into Hospitals & Clinics, Diagnostic Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among different countries, the United States dominates the global lateral flow assay market on account of the growing prevalence of infectious diseases and the demand for new technology with affordable costs in the country. Reported TB incidence (cases per 100,000 persons) increased by 9.4%, from 2.2 in 2020 to 2.4 in 2021 but was lower than incidence during 2019 (2.7). Increases occurred among both U.S.-born and non-U.S.-born persons.

Market Players

Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Quidel Corporation, Hologic, Inc., bioMerieux SA, PerkinElmer, Inc., Danaher Corporation, QIAGEN N.V. are some of the leading players operating in the Global Lateral Flow Assay Market.

Recent Developments

Novacyt, a specialist in clinical diagnostics, is to launch two PathFlow COVID-19 antigen lateral flow tests (LFTs) to strengthen its COVID-19 portfolio and to pursue new market opportunities, especially in point-of-care (POC) settings. In September 2020, F. Hoffmann-La Roche AG (Switzerland) launched a SARS-CoV-2 rapid antigen test kit and a SARS-CoV-2 rapid antibody test kit.

Report Scope

In this report, the global lateral flow assay market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Lateral Flow Assay Market, By Product:

  • Kits & Reagents
  • Lateral Flow Readers
  • Others

Lateral Flow Assay Market, By Application:

  • Clinical Testing
  • Cardiac Marker Testing
  • Pregnancy & Fertility Testing
  • Veterinary Diagnostics
  • Others

Lateral Flow Assay Market, By Technique:

  • Sandwich Assay
  • Competitive Assay
  • Multiplex Detection Assay

Lateral Flow Assay Market, By Test Type:

  • Lateral Flow Immunoassay
  • Nucleic Acid Lateral Flow Assay

Lateral Flow Assay Market, By End User:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Lateral Flow Assay Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lateral Flow Assay Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lateral Flow Assay Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 5.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 5.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 5.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 5.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 5.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 5.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 5.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By Technique
    • 5.3.4. By Test Type
    • 5.3.5. By End User
    • 5.3.6. By Region

6. North America Lateral Flow Assay Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 6.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 6.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 6.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 6.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 6.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 6.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 6.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Lateral Flow Assay Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Technique
        • 6.3.1.2.4. By Test Type
        • 6.3.1.2.5. By End User
    • 6.3.2. Mexico Lateral Flow Assay Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Technique
        • 6.3.2.2.4. By Test Type
        • 6.3.2.2.5. By End User
    • 6.3.3. Canada Lateral Flow Assay Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Technique
        • 6.3.3.2.4. By Test Type
        • 6.3.3.2.5. By End User

7. Europe Lateral Flow Assay Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 7.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 7.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 7.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 7.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 7.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 7.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 7.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Lateral Flow Assay Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Technique
        • 7.3.1.2.4. By Test Type
        • 7.3.1.2.5. By End User
    • 7.3.2. Germany Lateral Flow Assay Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Technique
        • 7.3.2.2.4. By Test Type
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Lateral Flow Assay Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Technique
        • 7.3.3.2.4. By Test Type
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Lateral Flow Assay Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Technique
        • 7.3.4.2.4. By Test Type
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Lateral Flow Assay Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Technique
        • 7.3.5.2.4. By Test Type
        • 7.3.5.2.5. By End User

8. Asia-Pacific Lateral Flow Assay Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 8.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 8.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 8.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 8.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 8.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 8.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 8.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Lateral Flow Assay Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Technique
        • 8.3.1.2.4. By Test Type
        • 8.3.1.2.5. By End User
    • 8.3.2. India Lateral Flow Assay Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Technique
        • 8.3.2.2.4. By Test Type
        • 8.3.2.2.5. By End User
    • 8.3.3. South Korea Lateral Flow Assay Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Technique
        • 8.3.3.2.4. By Test Type
        • 8.3.3.2.5. By End User
    • 8.3.4. Japan Lateral Flow Assay Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Technique
        • 8.3.4.2.4. By Test Type
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Lateral Flow Assay Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Technique
        • 8.3.5.2.4. By Test Type
        • 8.3.5.2.5. By End User

9. South America Lateral Flow Assay Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 9.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 9.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 9.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 9.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 9.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 9.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 9.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Lateral Flow Assay Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Technique
        • 9.3.1.2.4. By Test Type
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Lateral Flow Assay Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Technique
        • 9.3.2.2.4. By Test Type
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Lateral Flow Assay Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Technique
        • 9.3.3.2.4. By Test Type
        • 9.3.3.2.5. By End User

10. Middle East and Africa Lateral Flow Assay Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 10.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 10.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 10.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 10.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 10.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 10.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 10.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Lateral Flow Assay Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Technique
        • 10.3.1.2.4. By Test Type
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Lateral Flow Assay Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Technique
        • 10.3.2.2.4. By Test Type
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Lateral Flow Assay Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Technique
        • 10.3.3.2.4. By Test Type
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Lateral Flow Assay Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Thermo Fisher Scientific, Inc.
    • 15.6.2 Abbott Laboratories, Inc.
    • 15.6.3 F. Hoffmann-La Roche AG
    • 15.6.4 Bio-Rad Laboratories, Inc.
    • 15.6.5 Quidel Corporation
    • 15.6.6 Hologic, Inc.
    • 15.6.7 bioMerieux SA
    • 15.6.8 PerkinElmer, Inc.
    • 15.6.9 Danaher Corporation
    • 15.6.10 QIAGEN N.V.

16. Strategic Recommendations